Skip to main content
Drug bottle and Pill

Compare Ubrelvy vs. Rizatriptan

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Ubrelvy (ubrogepant) and Maxalt (rizatriptan) are both medications used to treat migraine attacks with or without aura. However, they belong to different medication classes. Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor blocker, while Maxalt is a triptan. Ubrelvy is taken orally in doses of 50 mg to 100 mg, with a maximum of 200 mg per day, and is not available in a generic form. Maxalt is available as a generic and comes in oral tablets and orally disintegrating tablets (ODT), with a typical adult dose of 5 mg to 10 mg and a maximum of 30 mg per day. Ubrelvy can cause side effects like nausea, sleepiness, and dry mouth, and it interacts with many medications, including certain antibiotics and seizure medications. Maxalt can cause dizziness, sleepiness, and heart-related side effects, and it interacts with antidepressants and other migraine medications. Additionally, Maxalt is approved for use in children ages 6 and older, while Ubrelvy is only for adults.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.